SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 366,652 shares at $25.85 ($9.4M) on 2023-06-15, disclosed to the SEC on 2023-06-20.
Open-market sale of $9.4M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.85 | 52,765 | $1.4M | 14.6% |
| 2 | $25.85 | 52,765 | $1.4M | 14.6% |
| 3 | $26.02 | 2,417 | $63K | 0.7% |
| 4 | $26.02 | 2,417 | $63K | 0.7% |
| 5 | $25.33 | 111,107 | $2.8M | 30.0% |
| 6 | $25.33 | 111,107 |
| $2.8M |
| 30.0% |
| 7 | $26.13 | 17,037 | $445K | 4.7% |
| 8 | $26.13 | 17,037 | $445K | 4.7% |
| Total | $25.56 avg | 366,652 | $9.4M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |